Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial.

ABSTRACT:

SUBMITTER: Arrieta O 

PROVIDER: S-EPMC8759028 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature